Research & Development
We rethink how medicines are made
Our R&D teams develop high-quality, patient-centered formulations – from affordable to innovative medicines. With scientific expertise and most modern labs, we turn ideas into effective therapies.
In-house R&D at its best
Advancing pharmaceutical development with science, speed, and purpose
At Tiefenbacher Group research and development is more than a function – it’s a mindset. Our in-house R&D forms the engine behind high-quality, affordable, and patient-centered pharmaceuticals. With a team of experienced scientists, most modern laboratories, and long-standing collaborations with leading universities, we develop a wide range of dosage forms across all major therapeutic areas. Whether it’s affordable, value-added, or innovative medicines, our goal is always the same: to improve patients’ lives with smarter, safer, and more effective therapies.
Facts & figures
Why partners trust our R&D: expertise, innovation, and real-world impact
Our advanced R&D operations combine scientific rigor with a deep understanding of patient and market needs. From formulation to regulatory strategy, we ensure that every development adds measurable value for our partners and for global healthcare. With strong IP guidance, GMP-certified labs, and experience across a wide range of dosage forms and technologies, we deliver smart, scalable, and safe solutions. Whether it’s optimizing bioavailability, reducing side effects, or creating new drug delivery systems, we make pharmaceutical innovation tangible.
New Development block at TIefenbacher Laboratories in India
Transforming pharmaceutical ideas into real-world therapies
At our new state-of-the-art R&D center in Hyderabad, India, we translate pharmaceutical innovation into scalable, regulatory-compliant products for global markets. Equipped with FDA-approved infrastructure and advanced technologies, we develop both affordable and value-added formulations.
- Major dosage forms – tablets, capsules, and liquids
- Most modern techniques incl. in-house XRD Crystallography, IVIVC WinNonlin simulation tools, Malvern particle size and Nitrosamine testing
- Strict GLP/GMP standards and international guidelines (ICH, EU, USFDA)
- ISO 14001:2014 and ISO 18001:2025 certifications
New Generation of Pharmaceuticals
Next-level R&D for highly potent drug formulations
With our new high-potent lab in Hyderabad, Tiefenbacher Group enters a new era of innovation. These next-generation pharmaceuticals, highly potent and effective at extremely low doses are developed under the highest containment and quality standards. We cover the full development process: from early-stage research to in-house commercial manufacturing.
- Development of highly potent oncology drugs up to OEB 5
- Tablets and capsules
- Contained equipment with closed material transfer system using containment charging & discharging compliant to OEL 5 level
- Already 25 leading highly potent drugs in pipeline
